DNMT3L and Hermansky-Pudlak syndrome: It is interesting to speculate that the observed hypomethylation of the DNMT3L promoter in normal gut mucosa in the HPS patients identified here, may also play a role in the aberrant de novo establishment of tumour suppressor methylation seen in most CRC.